ICON’s Commercialisation & Outcomes practices pr
Post# of 30028
Posted On: 09/02/2014 6:52:51 AM
Re: brickbybrick #5174
ICON’s Commercialisation & Outcomes practices provide insights to clients on strategies and execution for long-term value through customised engagements that fit the compound, the company and the market, maximising products' success and their benefits to patients’ health.
The combined strengths in our scientific practices and operational delivery teams offer tremendous opportunity to harness expertise and capabilities from multiple disciplines at once, or in sequence, creating a stronger and more persistent focus on product value and commercial success.
Specialty practices directed toward product commercialisation include:
Peri-approval & Observational Research
Pricing & Market Access
Health Economics
Patient Reported Outcomes
Epidemiology
Electronic Clinical Outcomes Assessment
The combined strengths in our scientific practices and operational delivery teams offer tremendous opportunity to harness expertise and capabilities from multiple disciplines at once, or in sequence, creating a stronger and more persistent focus on product value and commercial success.
Specialty practices directed toward product commercialisation include:
Peri-approval & Observational Research
Pricing & Market Access
Health Economics
Patient Reported Outcomes
Epidemiology
Electronic Clinical Outcomes Assessment
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼